Reducing bloodstream infections from ICU catheters
Part of Infections clinical trials.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been in the intensive care unit (ICU) for at least 48 hours
- You have a central line (a large IV placed in a vein in your neck, chest, or groin) for more than 24 hours
- You are not pregnant
- You have never had a bloodstream infection from a central line before
- Your central line was placed in this hospital (not brought in from another hospital)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This study tests a special locking solution placed in central venous catheters (thin tubes in babies' veins) to prevent infections. Researchers want to see if this approach keeps newborns safer during hospital care.
This study aims to reduce infections that can happen when you have a central line, a special tube placed in a large vein to give medicines or fluids. Participating may help improve safety for patients like you.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
This study tests a new approach to prevent infections on central venous catheters (thin tubes inserted into large veins) in hospital intensive care units. Researchers will study catheters that already show signs of bacterial growth to understand how to better protect patients from catheter-related infections.
This study is about finding how common bloodstream infections are in people with central lines (a special IV for long-term medicines). It will help doctors learn how to prevent these infections.
Hear when a new CLABSI - Central Line Associated Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.